Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Dosage Form : Tablet
Packaging Type :
Packaging :
Price : ₹1/-
Emplozin M 12.5/500 Tablet is a combination of Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Metformin, a biguanide class antidiabetic drug. This combination works synergistically to help manage Type 2 diabetes mellitus by lowering blood sugar levels. Empagliflozin works by preventing the reabsorption of glucose from the kidneys, increasing glucose excretion through urine. Metformin primarily reduces hepatic glucose production and improves insulin sensitivity, both of which contribute to better control of blood sugar.
This dual-action tablet is used in patients who cannot adequately control their blood sugar levels through diet, exercise, or single-drug therapy alone. It can be prescribed for adult patients with Type 2 diabetes as part of a comprehensive diabetes management plan, often along with diet and exercise.
May cause nausea, vomiting, diarrhea, or dehydration; rare cases of lactic acidosis.
For the management of Type 2 diabetes mellitus, used alongside diet and exercise to control blood sugar levels.
Not recommended for patients with severe kidney issues or metabolic acidosis; regular monitoring of kidney function is advised.
Composition : Empagliflozin (25mg)
Composition : Empagliflozin (10mg)
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin 100mg
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)